Clinical Case Seminar: Postmenopausal Androgen Excess - Challenges in Diagnostic Work-Up and Management of Ovarian Thecosis

October 2017 in “ Clinical Endocrinology ”

Yaasir Mamoojee, Murali Ganguri, Norman Burke Taylor, Richard Quinton

postmenopausal hyperandrogenism hirsutism androgenic alopecia serum testosterone GnRH suppression test spironolactone bilateral salpingo-oophorectomies ovarian hyperthecosis virilizing ovarian tumors low-dose dexamethasone suppression test steroid metabolomic profiling insulin resistance testosterone GnRH test ovarian tumors dexamethasone test steroid profiling

Studysummary This article reviews existing knowledge on postmenopausal hyperandrogenism and highlights diagnostic challenges, reporting no new clinical results.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

The document presented a case of a 72-year-old woman with postmenopausal hyperandrogenism, characterized by hirsutism, androgenic alopecia, and voice deepening. Elevated serum testosterone levels and imaging suggested a benign ovarian cause, which was confirmed by a GnRH suppression test. The patient was treated with spironolactone and later underwent bilateral salpingo-oophorectomies, resulting in normalized hormonal profiles and improved hirsutism. The document highlighted the diagnostic challenges in distinguishing between ovarian hyperthecosis (OH) and virilizing ovarian tumors (VOTs), noting that while certain tests can identify the source of androgen excess, they cannot reliably differentiate between OH and VOTs. It also discussed the limitations of the low-dose dexamethasone suppression test in insulin-resistant women and the potential of steroid metabolomic profiling as a future diagnostic tool. The document concluded that bilateral laparoscopic salpingo-oophorectomy is the preferred treatment for postmenopausal hyperandrogenism, with medical therapy as an alternative or interim measure, and emphasized the importance of addressing insulin resistance for diagnostic and therapeutic purposes.

View this study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Research cited in this study

7 / 7 results

Discriminating Between Virilizing Ovary Tumors and Ovary Hyperthecosis in Postmenopausal Women: Clinical Data, Hormonal Profiles, and Imaging Studies

research Discriminating Between Virilizing Ovary Tumors and Ovary Hyperthecosis in Postmenopausal Women: Clinical Data, Hormonal Profiles, and Imaging Studies

27 citations , April 2017 in “European journal of endocrinology”

This retrospective study found that serum hormone levels and MRI detection of ovarian nodules contributed to distinguishing virilizing ovarian tumors from ovarian stromal hyperthecosis in postmenopausal women, though histopathology remains crucial for diagnosis.

research Management of Endocrine Disease: Hyperandrogenism After Menopause

84 citations , September 2014 in “European journal of endocrinology”

This review examines the causes and characteristics of androgen excess in postmenopausal women, but reports no new clinical results; the authors emphasize challenges in diagnosis and potential long-term health impacts.

Risk of Meningioma Among Users of High Doses of Cyproterone Acetate Compared With the General Population: Evidence From a Population-Based Cohort Study

research Risk of Meningioma Among Users of High Doses of Cyproterone Acetate Compared With the General Population: Evidence From a Population-Based Cohort Study

88 citations , May 2011 in “British Journal of Clinical Pharmacology”

This study found that high doses of cyproterone acetate were associated with an increased risk of meningioma, especially with exposure longer than one year.

research Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline

502 citations , February 2008 in “The Journal of Clinical Endocrinology & Metabolism”

This review discusses hirsutism management guidelines, recommending androgen testing only for women with abnormal hirsutism scores and advocating for combined therapy approaches depending on severity and underlying conditions, but it reports no new clinical results.

The Investigation and Management of Severe Hyperandrogenism Pre- and Postmenopause: Non-Tumor Disease Is Strongly Associated with Metabolic Syndrome and Typically Responds to Insulin-Sensitization with Metformin

research The Investigation and Management of Severe Hyperandrogenism Pre- and Postmenopause: Non-Tumor Disease Is Strongly Associated with Metabolic Syndrome and Typically Responds to Insulin-Sensitization with Metformin

14 citations , January 2008 in “Gynecological Endocrinology”

This study reports that in women with non-tumor hyperandrogenism, a decrease in serum testosterone from insulin-sensitizing therapy like metformin may indicate a low likelihood of having an androgen-secreting tumor.

research Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOS)

4025 citations , December 2003 in “Human Reproduction”

This review discusses the evolution of diagnostic criteria for polycystic ovary syndrome and emphasizes its association with various metabolic and cardiovascular risks, but it provides no new research findings.

A Prospective Study of the Prevalence of Clear-Cut Endocrine Disorders and Polycystic Ovaries in 350 Patients Presenting with Hirsutism or Androgenic Alopecia

research A Prospective Study of the Prevalence of Clear-Cut Endocrine Disorders and Polycystic Ovaries in 350 Patients Presenting with Hirsutism or Androgenic Alopecia

135 citations , August 1994 in “Clinical Endocrinology”

In this study of women with hirsutism or androgenic alopecia, diverse underlying endocrine disorders including polycystic ovaries and various enzyme deficiencies were detected, often associated with elevated testosterone levels.